SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-029930
Filing Date
2024-04-03
Accepted
2024-04-03 17:21:23
Documents
1
Period of Report
2024-04-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4306
  Complete submission text file 0001213900-24-029930.txt   5723
Mailing Address 818 A1A NORTH, SUITE 100 PONTE VEDRA BEACH FL 32082
Business Address
Cole Jeffrey Scott (Reporting) CIK: 0001751100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41596 | Film No.: 24820129

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)